Stool Testing for Pancreatic Cancer

Completed

Conditions studied: Pancreatic Cancer

In brief

The purpose of this study is to determine if pancreatic cancer/pre-cancer can be detected in early stages through the molecular analysis of stool samples. Investigators hypothesize that analysis of stool samples using digital melt curve (DMC) analysis, can be used as a sensitive and specific method to detect the common genetic abnormalities present in pancreatic cancers and pre-cancerous lesions of the pancreas.

Key facts

Study ID

NCT01104129

Run by

Columbia University

People needed

158

Starts

2009-07-09

Expected to finish

2016-11-29

Last updated by the study team

2021-01-19

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years of age and older.
• Tissue-confirmed or radiological evidence of either pancreatic adenocarcinoma or intrapapillary mucinous neoplasm(IPMN).
• Scheduled for surgical resection of the adenocarcinoma or IPMN.
• Able to give informed consent

You may not qualify if…

• History of colorectal, gastric cancer, esophageal, or head-and-neck cancer.
• Endoscopic procedure conducted less than 1 week prior to enrollment.
• Unwillingness or inability to sign informed consent.

Where it is running

• Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.